Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis

Abstract

In this trial, the major risk factors for developing joint symptoms were previous HRT, hormone-receptor positivity, previous chemotherapy, obesity, and treatment with anastrozole. Discussion of identified risk factors is appropriate when counselling women before initiation of adjuvant hormonal treatment.